Improving emergency treatment for prolonged seizures
Prehospital management of status epilepticus
This study looks at how emergency medical teams treat people having severe seizures and aims to understand why they sometimes don't use important medications, so they can improve care for patients in these situations.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10808042 on NIH RePORTER |
What this research studies
This research investigates how emergency medical services (EMS) manage status epilepticus, a serious condition affecting many individuals each year. It aims to identify the reasons behind the inconsistent use of benzodiazepines, which are critical for treating this condition, and to analyze how these practices impact patient outcomes. By examining EMS electronic medical records and linking them to hospital data, the study seeks to uncover the factors influencing treatment decisions and ultimately improve care for patients experiencing prolonged seizures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who experience status epilepticus or are at risk of having prolonged seizures.
Not a fit: Patients who do not experience status epilepticus or have other unrelated medical conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better emergency treatment protocols for status epilepticus, potentially reducing morbidity and mortality associated with this condition.
How similar studies have performed: Previous research has shown that improving EMS protocols can lead to better patient outcomes, indicating that this approach has potential for success.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Guterman, Elan — University of California, San Francisco
- Study coordinator: Guterman, Elan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.